Since 1998, this community has helped people find opportunities, build careers, and connect across the industry. As we close this chapter, we do so with gratitude and pride in what we created together ...
Likozam® will be reimbursed to patients starting June 12, 2026 Official reimbursement ends the “Early Access” clawbackThe price obtained offsets the discounts owed under the early access program and ...
Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its potential to deliver best-in-class weight loss across a broad population of people living with ...
Oral and poster presentations span three priority programs in breast, gynecologic, and gastrointestinal cancers, advancing rapidly toward pivotal developmentCompany to host investor webcast showcasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results